Drug Transport and Resistance Mechanisms
Drug Transport and Resistance Mechanisms is a research topic within Oncology. Science Explorer counts 57k research works in it since 1950. 24.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the mechanisms of multidrug resistance in cancer, focusing on the role of ATP-dependent transporters, P-glycoprotein, bile acids, ABC transporters, and drug efflux pumps. It also delves into the involvement of nuclear receptors, metabolic regulation, and the impact on intestinal barrier function.
- Multidrug Resistance
- ATP-dependent Transporters
- P-glycoprotein
- Bile Acids
- ABC Transporters
- Drug Efflux Pumps
- Nuclear Receptors
- Cancer Chemotherapy
- Metabolic Regulation
- Intestinal Barrier
- Research works
- 57k fractional, since 1950
- In the world top 10%
- 14k per year above
- Top-10% rate
- 24.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -2% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Drug Transport and Resistance Mechanisms research?
By volume, China and the United States publish the most (1.5k and 959 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.5k works
- 2 United States 959 works
- 3 India 343 works
- 4 Japan 286 works
- 5 Germany 200 works
- 6 United Kingdom 143 works
- 7 Italy 121 works
- 8 South Korea 119 works
- 9 France 114 works
- 10 Türkiye 83 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Drug Transport and Resistance Mechanisms research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Drug Transport and Resistance Mechanisms research, followed by China Pharmaceutical University and Sun Yat-sen University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 25 works
- 2 China Pharmaceutical UniversityChina 24 works
- 3 Sun Yat-sen UniversityChina 20 works
- 4 University of WashingtonUnited States 20 works
- 5 Shanghai University of Traditional Chinese MedicineChina 19 works
- 6 Sichuan UniversityChina 19 works
- 7 Peking UniversityChina 17 works
- 8 Zhejiang UniversityChina 17 works
- 9 Shanghai Jiao Tong UniversityChina 16 works
- 10 King Saud UniversitySaudi Arabia 16 works
Who are the leading researchers in Drug Transport and Resistance Mechanisms?
The most-cited researchers publishing on Drug Transport and Resistance Mechanisms include Guido Kroemer and Daniel Levy.
- 1 Guido Kroemer France 4.2k citations
- 2 Daniel Levy United States 3.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Drug Transport and Resistance Mechanisms research done?
The largest centres of Drug Transport and Resistance Mechanisms research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China).
Where is the best place to study Drug Transport and Resistance Mechanisms?
Among universities, judged by research, China Pharmaceutical University, Shanghai University of Traditional Chinese Medicine and Beijing University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Pharmaceutical UniversityChina | 72.7 | 34.5% | 21.9× | 24 | +19.3% |
| 2 | Shanghai University of Traditional Chinese MedicineChina | 70.1 | 39.3% | 19.1× | 19 | -4.8% |
| 3 | Beijing University of Chinese MedicineChina | 66.9 | 36.8% | 10.3× | 9 | +149.4% |
| 4 | King Saud UniversitySaudi Arabia | 56.4 | 34.6% | 3.4× | 16 | +20.5% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 55.8 | 30.8% | 5.2× | 25 | -17.3% |
| 6 | Nanjing University of Chinese MedicineChina | 55.4 | 34.2% | 7.7× | 10 | +95.5% |
| 7 | Guangdong Pharmaceutical UniversityChina | 53.4 | 26.1% | 21.4× | 11 | +31.9% |
| 8 | Zhejiang Chinese Medical UniversityChina | 52.8 | 33.4% | 8.2× | 11 | +32.1% |
| 9 | Chengdu University of Traditional Chinese MedicineChina | 51.3 | 23.9% | 9.9× | 11 | +42.5% |
| 10 | Shanghai Jiao Tong UniversityChina | 49.0 | 39.7% | 1.5× | 16 | +28.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Drug Transport and Resistance Mechanisms research growing?
Output in 2018–2022 was 2% lower than in 2013–2017, peaking in 2013. The fastest-growing topics are Drug Transport and Resistance Mechanisms.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.